Biotechnology Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1942 | AUPH Aurinia Pharmaceuticals Inc - Common Shares | 16.31 USD | -2.04% | +6.05% | +5.43% | +36.71% | 2.17 B USD | ||
| 1949 | ADMA ADMA Biologics Inc - Common Stock | 9.72 USD | -1.22% | +2.10% | +15.99% | -44.90% | 2.18 B USD | ||
| 1954 | VCEL Vericel Corporation - Common Stock | 42.66 USD | -0.05% | -3.05% | -6.20% | +17.36% | 2.18 B USD | ||
| 1961 | MESO Mesoblast Limited - American Depositary Shares | 16.44 USD | -3.29% | -3.92% | +9.75% | +2.75% | 2.10 B USD | ||
| 1978 | NBTX Nanobiotix S.A. - ADSs | 39.72 USD | -8.79% | +0.28% | -0.10% | +321.66% | 1.92 B USD | ||
| 1979 | ZBIO Zenas BioPharma, Inc. - Common Stock | 31.24 USD | -3.25% | +6.01% | +1.07% | +18.07% | 2.04 B USD | ||
| 1985 | BHVN Biohaven Ltd. Common Shares | 13.74 USD | -0.79% | -4.45% | -6.78% | -18.89% | 2.08 B USD | ||
| 1987 | STOK Stoke Therapeutics, Inc. - Common Stock | 31.75 USD | -1.67% | +1.37% | +7.34% | +62.49% | 2.05 B USD | ||
| 1991 | XNCR Xencor, Inc. - Common Stock | 27.28 USD | -1.87% | +17.28% | +40.04% | +225.54% | 2.03 B USD | ||
| 2008 | ZYME Zymeworks Inc. - Common Stock | 27.30 USD | -4.78% | +8.59% | +18.34% | +53.89% | 1.94 B USD | ||
| 2018 | SRPT Sarepta Therapeutics, Inc. - Common Stock | 18.19 USD | -3.19% | +0.94% | +10.44% | -10.13% | 1.92 B USD | ||
| 2020 | TSHA Taysha Gene Therapies, Inc. - Common Stock | 5.87 USD | -3.61% | -2.33% | +3.71% | +95.67% | 1.91 B USD | ||
| 2026 | AGIO Agios Pharmaceuticals, Inc. - Common Stock | 33.07 USD | -0.06% | -0.87% | -8.72% | -23.78% | 1.97 B USD | ||
| 2045 | IMCR Immunocore Holdings plc - American Depositary Shares | 36.04 USD | -2.28% | +5.91% | +2.80% | +7.65% | 1.86 B USD | ||
| 2054 | RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.30 USD | -5.71% | +6.11% | +8.55% | -34.00% | 1.77 B USD | ||
| 2057 | SEPN Septerna, Inc. - Common Stock | 40.34 USD | +0.85% | -9.96% | +21.32% | +83.28% | 1.88 B USD | ||
| 2077 | NTLA Intellia Therapeutics, Inc. - Common Stock | 12.40 USD | -3.43% | +4.20% | +12.01% | -9.62% | 1.74 B USD | ||
| 2098 | GHRS GH Research PLC - Ordinary Shares | 27.45 USD | -3.11% | -6.41% | -1.47% | +93.86% | 1.70 B USD | ||
| 2099 | SNDX Syndax Pharmaceuticals, Inc. - Common Stock | 19.26 USD | -1.98% | -2.28% | -8.68% | +18.45% | 1.72 B USD | ||
| 2103 | FTRE Fortrea Holdings Inc. - Common Stock | 18.27 USD | -0.65% | +4.70% | -6.36% | +119.06% | 1.74 B USD |
Noticias Biotechnology Stocks
Deutsche Bank rebaja argenx a Mantener por valoración
¿Por qué cae hoy la acción de Monte Rosa Therapeutics?
Las acciones de Biomea Fusion se disparan tras completar el ensayo sobre diabetes
Las acciones de Monte Rosa caen al inicio de un estudio de fase 2 contra el cáncer de próstata
Las acciones de Crinetics Pharmaceuticals alcanzan máximos históricos en 84,8 dólares
H.C. Wainwright reitera su calificación de Biomea Fusion tras inscripción en ensayo
La FDA amplía la revisión de deramiocel de Capricor hasta el 22 de noviembre
Gainers Biotechnology Stocks
SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
ELOX Eloxx Pharmaceuticals, Inc. | 20.97 | +16.24% |
Losers Biotechnology Stocks
OABIW OmniAb, Inc. - Warrant | 0.1700 | -40.27% |
CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0131 | -17.09% |
ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |